Skip to content

Companies Investors Funds People Markets

/

Loading company…

Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute
API

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

© 2026 CapbaseData CC BY-NC 4.0 · Code AGPL-3.0support@capbase.fyi

Goldenrod Therapeutics, Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

G

Goldenrod Therapeutics, Inc.

Private

Biotechnology

SEC CIK: 0002127885

Founded: 2023Source: [SEC]
Headquarters: HOUSTON, TEXASSource: [SEC]
Country: United StatesSource: [SEC]
Headcount: 0Source: [SEC]
Stage

$3.2MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Overview

Funding rounds

2 rounds

2 rounds · latest Private placement (Form D), May 2026 · $3.2M raised

Sign in to see 2 rounds.

Investors

2 on file

Sign in to see 2 investors.

People

Leadership

Leo Linbeck IIIDirectorSince 2026Source: [SEC]

Atul VaradhacharyExecutive OfficerSince 2026Source: [SEC]

Acquisitions

Goldenrod Therapeutics, Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Diversity investments

No diversity signals recorded yet for Goldenrod Therapeutics, Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Seed

Sector

Healthcare

Operating status

Sign in to see 4 more people.